首页> 外文期刊>Indian journal of cancer. >Prophylactic beclomethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study.
【24h】

Prophylactic beclomethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study.

机译:乳腺癌术后放疗期间对皮肤预防性倍氯米松喷雾:一项前瞻性随机研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIMS: Radiation induced wet desquamation of skin in carcinoma breast patients is a painful condition. In this study topical beclomethasone dipropionate spray was used as prophylaxis with the purpose of reducing risk of the wet desquamation of skin in irradiated field. MATERIALS AND METHODS: Sixty patients of carcinoma breast were planned for postoperative loco regional radiotherapy (50 Gy in 25 fraction over five weeks) were prospectively randomized into two groups (1) steroid group-patients were advised to use beclomethasone dipropionate spray in irradiated axilla from day one of radiotherapy, (2) control group-patients were not allowed to use any topical agent in irradiated area. Radiation induced skin reaction was noted in terms of erythema, dry desquamation and wet desquamation weekly till end of prescribed 50 Gy dose of the radiation therapy. STATISTICAL METHOD: Chi-square test was used to see the statistical significance of the difference in wet desquamation between two arms of thestudy. Chi-square value and P-value was calculated for the difference of wet desquamation in two study arms. RESULT: In steroid group 4/30 (13.33%) patients developed wet desquamation of the axillary skin at the end of the radiotherapy. For the control group, this figure was 11/30 (36.66%). The difference in wet desquamation of the axillary skin in the two groups was statistically significant (P-value = 0.0369). CONCLUSION: Topical steroid (beclomethasone dipropionate spray) for skin during radiotherapy significantly reduces the risk of wet desquamation of the skin.
机译:背景与目的:辐射诱发乳腺癌乳腺癌患者皮肤的湿性脱皮是一种痛苦的状况。在这项研究中,局部使用倍氯米松双丙酸酯喷雾剂作为预防剂,目的是降低照射场中皮肤湿法脱皮的风险。材料与方法:计划对60例乳腺癌的乳腺癌患者进行术后局部局部放疗(5周内在25个部位进行50 Gy的放疗),前瞻性随机分为两组(1)类固醇组患者,建议使用丙酸倍氯米松二丙酸酯喷雾剂治疗放疗的第一天,(2)对照组患者不允许在受辐照区域使用任何局部用药。辐射引起的皮肤反应以红斑,干法脱皮和湿法脱皮的方式记录,直到规定的50 Gy剂量的放射治疗结束为止。统计方法:使用卡方检验来研究研究的两个分支之间的湿法脱皮差异的统计学意义。计算两个研究组中湿法脱皮的差异的卡方值和P值。结果:类固醇组4/30(13.33%)患者在放疗结束时出现腋窝皮肤湿性脱屑。对于对照组,这个数字是11/30(36.66%)。两组腋下皮肤湿法脱屑的差异具有统计学意义(P值= 0.0369)。结论:放疗期间局部使用类固醇(倍氯米松双丙酸酯喷雾剂)可显着降低皮肤湿法脱皮的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号